Drugs in Dev.
Immunology
Discovery
Poland 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Discovery
Sponsor : Galapagos
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Galapagos and Ryvu Announce Research Collaboration
Details : In this joint reaserch collaboration, Ryvu is responsible for early drug discovery. Galapagos will have an exclusive option to license IP developed by Ryvu.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 16, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Discovery
Sponsor : Galapagos
Deal Size : Undisclosed
Deal Type : Licensing Agreement
